Story Poster
Photo by Steve Murphy/Inside Pack Sports
NC State Baseball

IPS IN 5: Projection vs. Production

July 3, 2024

IPS In 5 is now sponsored by Murphy Insurance.  Call Murphy Insurance for all your business insurance needs.  Insurance is only as good as your agent.   Let it be Murph!  Contact us today at 910.693.3422 or online at

NC State landed another big commitment out of the portal in Vanderbilt first baseman Matt Ossenfort who was highly-regarded coming of out high school.  He's the second transfer the Pack's added with big-time upside but a small sample size of success on the college level.

NOTE: There are four ways you can access the content.

  • By clicking the video player above to watch a streaming video with our comments.
  • You can also click the link below to listen.  To download the file, right click and save the link below as a .mp3 file to listen later.

IPS IN 5: Projection vs. Production (18:04)

  • By clicking the music player below.

IPS IN 5: Projection vs. Production

1,237 Views | 2 Replies | Last: 12 days ago by wilmwolf
How long do you want to ignore this user?
hooooo boy James...Gino Groover was night and day better than Amak. Amak was NEVER the type of hitter Gino was. Also no one saw Amak hitting almost 100 points HIGHER than his career best. Literally no one projected that. That's a flimsy argument, IMO.

Hell, Garrett hit 43 points higher than at Wichita State, his one year of D1 ball. No one projected him to hit over .350 stepping up into the ACC. I thought the power numbers would be there but never dreamed he'd hit .350.

Sosa was the opening day DH so he was in the lineup game 1.
How long do you want to ignore this user?
And AMak didn't just have a career year, he had one of the best power hitting years in the history of NC State. Anyone who saw that coming needs to be playing the lotto.
Just a guy on the sunshine squad.
The Gatekeeper.
Page 1 of 1
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.